Subcutaneous Extended-Release Buprenorphine Use in Pregnancy

BACKGROUND: Opioid use disorder (OUD) in pregnancy is managed by medication-assisted treatment. Sublingual buprenorphine is one option, but subcutaneous extended-release buprenorphine (Sublocade®) is an alternate form administered in monthly injections. Through an extensive literature search, we did...

Descripción completa

Detalles Bibliográficos
Autores principales: Towers, Craig V., Deisher, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382717/
https://www.ncbi.nlm.nih.gov/pubmed/32724686
http://dx.doi.org/10.1155/2020/3127676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382717/
https://www.ncbi.nlm.nih.gov/pubmed/32724686
http://dx.doi.org/10.1155/2020/3127676

Ejemplares similares